Koninklijke Philips N.V.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Koninklijke Philips N.V. is a global health technology company headquartered in Amsterdam, Netherlands, founded in 1891. It operates mainly across the diagnosis and treatment, connected care, and personal health segments, offering a broad range of products and services including precision diagnostic imaging systems, image-guided therapy solutions, patient monitoring devices, health informatics, respiratory care, and personal health and home care products. Its core portfolio features advanced diagnostic imaging devices such as CT and ultrasound systems, AI-enabled clinical decision support tools, enterprise health informatics platforms, sleep and respiratory care solutions, and consumer health categories including grooming and oral healthcare devices. Philips serves markets primarily in North America, Western Europe, Greater China, and other growth geographies. Recent developments include the launch of the AI-powered Philips CT 5300 system, integrating advanced hardware and software with artificial intelligence to enhance imaging quality and boost clinical workflow efficiency. This system offers ultra-low dose screening capabilities and improved diagnostic confidence with smart workflow automation. Philips has also introduced two FDA-cleared AI applications for its Lumify point-of-care ultrasound system, enabling smarter, faster frontline care in anesthesia, emergency medicine, and critical care. Strategically, Philips has maintained cost discipline, restructuring its supply chain and reducing overhead while investing selectively in innovation projects. The company reported a reduced M&A spend in 2023 compared to 2022, focusing on operational improvements and cash preservation. Philips’ business model is arranged into global, end-to-end business units—Diagnosis & Treatment, Connected Care, and Personal Health—each managing their operations independently. Notably, the company is investing in improving productivity and operational efficiency with multi-year savings programs and enhanced product pipeline focus. Its recent partnerships include collaborations with healthcare institutions such as Hôpital Fondation Rothschild in Paris and Erasmus University Medical Center. Philips aims to improve 2.5 billion lives annually by 2030, reflecting its strategic commitment to health technology innovation and broad accessibility. Financially, Philips generated approximately $19.5 billion in revenue in 2024, employing around 67,800 people globally. The company continues to navigate challenges such as supply chain disruptions and market demand fluctuations, particularly in China, while driving growth in mature markets and leveraging AI and digital technologies to reinforce its competitive position in healthcare technology. Its leadership in diagnostic imaging, patient monitoring, connected care, and personal health makes it a key player in the global health technology industry.
Company News
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC
Philips advances women's health ultrasound with new single-transducer solution
Financial Analysis: Koninklijke Philips (NYSE:PHG) & Microbot Medical (NASDAQ:MBOT)
Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration
Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration
Philips selected for ARPA-H program to advance AI-enabled robotic stroke care
Philips prices EU green bond for EUR 650M
Bank of America Corp DE Purchases 50,124 Shares of Koninklijke Philips N.V. $PHG
Philips, Shell targeted by hacking group
Agnelli family's Exor can raise Philips stake to 22% under updated agreement
Exor and Philips Extend Long-term Relationship Agreement
Cetera Investment Advisers Acquires 45,968 Shares of Koninklijke Philips N.V. $PHG
Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside
Arrowstreet Capital Limited Partnership Acquires Shares of 53,956 Koninklijke Philips N.V. $PHG
Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation
Philips Avent introduces new automated SMS-based tool to help moms activate their village during postpartum
Koninklijke Philips: Solid Execution Supports Our Buy Rating
Philips Q2 Earnings and Revenues Increase Year over Year, Shares Down
Koninklijke Philips N.V. (PHG) Q2 2026 Earnings Call Transcript
Philips Shares Fall After Orders Slip